LEE SUNG (EVP, Chief Financial Officer) sold 5.4% of their position (4.93K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $306.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2026ACC: 0001061983-26-000029
Officer· EVP, Chief Financial Officer
Since Apr 2024
-4.93K
Net shares
Net seller
$306.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.93K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.93K
Price / share
$62.15
Trade value
$306.71K
% of position
5.4%
3/17/2026
92.06K→87.13K
Total
Net shares
−4.93K
Net value
-$306.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −4.93K | $62.15 | $306.71K | 5.4% | 92.06K | 87.13K |
| Total | −4.93K | -$306.71K | ||||||
Derivative Transactions0
No derivative transactions reported